Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
It’s simply a case of an illiquid stock, having a steel holder who is trying to exit fast. Once they have sold, this will reverse very quickly
165p all buys.
Despite them saying no contracts have been cancelled, the reorganisation of higher margin projects into this year is feedimg into market nervousness about heat pump uptake more generally. Market suspects a bit of a cover up and has overeacted a bit (i think).
Day traders turning up too...
"To date we have funded through cash and debt facilities, would expect to continue business using debt facilities"
"Operating well within Debt capacity at the moment"
Estimates for PBT:
FY24 £7m
FY25 £9m
"The group still owns nearly 66% and we are aligned with shareholders and will recover the share price going forward"
Small free float, buy.
It overdone, so great opp for all buyers/ holders. period
Continues to drop it seems, can buy at 159-160p currently, agree that it seems odd based on the numbers in the RNS. I think it's a reflection of the below market-expectations of numbers that's done it, doesn't matter how good they appear if the market expected otherwise then it will be priced accordingly. Seems relatively good at this level IMO (IGNORE MAGS AT ALL COSTS, HE WILL RAMP THIS TO HIGH HEAVEN, DYOR)
:)
This should have dropped below 2.20
you sill see, if you sell to early etc
Share price has dropped, is it going to continue going down, any idea why? The company as a whole seems to be doing well.
Some very good buys under 2p
should close strong here,
buy up the lows and hold well
once the bottom fishing has been done it will move up
Perfect buying opportunity for future profits. Drop overdone, will be a market correction shortly.
The RNS states decline to high single digit PBT margins. By my calcs, the previous consensus for 2024 sales was £80m and PBT £11.7m. On a margin of 9% this gives you PBT of £7.3m, a 38% decline versus expectations. This may be partly mitigated by higher sales but they state sales being higher than management, not market expectations
175p to buy and not much, shows how over sold this is now - period
if you hold add and relax here. You may do very well going forward
Hi Mag - good to see you here!
Massive recovery coming here this afternoon.
Investor webinar at 11.00.. link is shown a few posts down!
For a company that has just announced £10m of profit.
Lol.
The RNS IS CLEAR - the company is well funded.
Little to no risk of a fundraise here, in my opinion.
Losing 95p just like that is silly, when results were all factored in weeks ago
Ragnar (nice nice btw!),
I'm not sure I agree with what you're saying.. FY23 was £10.1m PBT and the RNS indicates "High single figure" PBT for FY24 with roughly £80m revenue - that doesn't sound like a 35% reduction to me!
Record order book which may well yet get bigger during the financial year, and if you can factor in any revenues into FY24 from those orders, you may well be looking double digit PBT again..
Margins are always going to be tighter - we are in a crazy world at the moment... But the company appears to be super bullish on the short to mid term outlook in an extremely high interest sector.
There are plenty of companies out there with a bigger mcap than this - that are loss making year upon year.
This is a HUGE overreaction - the SP opened at £2.60 which tells you everything you need to know - this drop wasn't necessarily foreseen by the MMs.
Not much cash in the bank, expect it to drop to £1.20 before bouncing
Market can be dumb sometimes,
some big buys seen today, it was already oversold and any jitters already factored in
they are a solid business
They’ve INCREASED the dividend for goodness sake! By 2%. Which rn is probs more like 6%!! Crazy
A tad overdone here, it was already oversold at 220p
buy up low while you can
should bump up
This is the most absurd overreaction I've ever seen in the markets
The RNS indicates a 35% reduction in 2024 profit and EPS despite revenue being a little better. The language of the RNS is quite deceptive. A more clear and perhaps cynical explanation would read:
"reduction in 2024 profit margin from 15% to 9% and profit from 11m to 7m. 2023 performance was inflated by bringing forward high value contracts from the following financial year. The fundamentals of the business are less certain given a high reliance on a small number of very high value projects which are not expected to continue next year but we hope will feature in 2025"
Gives an absolutely bonkers P/E of 6